← back to search

José Domínguez

Instituto de Investigación de Enfermedades Raras · ES
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Infectious Diseases and Tuberculosis, and Pneumonia and Respiratory Infections.
h-index
45
citations
6,854
works
265
NIH funding
primary concept
Medicine
email

Recent publications

Rapid and portable molecular test for <i>Mycobacterium</i> sp. based on double-tagging amplification and electrochemical readout
Sensors &amp; Diagnostics 2026cited by 0position: contributordoi
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study
The Lancet Regional Health - Europe 2025cited by 8position: middledoi
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
ERJ Open Research 2024cited by 44position: middledoi
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
The Lancet Infectious Diseases 2023cited by 83position: firstdoi
Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis
EClinicalMedicine 2023cited by 66position: middledoi
Tuberculosis incidence in foreign-born people residing in European countries in 2020
Eurosurveillance 2023cited by 17position: middledoi
Pooling sputum testing to diagnose tuberculosis using xpert MTB/RIF and xpert ultra: a cost-effectiveness analysis
BMC Infectious Diseases 2023cited by 15position: middledoi
Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
2023cited by 1position: middledoi
Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19 – changing paradigms?
ERJ Open Research 2022cited by 29position: middledoi
Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment
Frontiers in Microbiology 2022cited by 15position: middledoi
Effect of Hysteroscopic Metroplasty on Reproductive Outcomes in Women with Septate Uterus: Systematic Review and Meta-Analysis
Journal of Minimally Invasive Gynecology 2021cited by 60position: middledoi
Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children
Scientific Reports 2021cited by 19position: lastdoi
Use and impact of molecular methods for detecting drug‐resistant TB
The International Journal of Tuberculosis and Lung Disease 2021cited by 3position: middledoi
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
Nature Medicine 2020cited by 108position: middledoi
Impact of COVID-19 on Tuberculosis Control
Archivos de Bronconeumología 2020cited by 55position: lastdoi
Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
Scientific Reports 2020cited by 43position: lastdoi
Bedaquiline and Delamanid for Drug-Resistant Tuberculosis: A Clinician’s Perspective
Future Microbiology 2020cited by 26position: middledoi
Molecular Detection of Mycobacterium tuberculosis in Oral Mucosa from Patients with Presumptive Tuberculosis
Journal of Clinical Medicine 2020cited by 25position: lastdoi
Novel Intracellular Antibiotic Delivery System Against <i>Staphylococcus Aureus</i> : Cloxacillin-Loaded Poly( <scp>D</scp> , <scp>L</scp> -Lactide-Co-Glycolide) Acid Nanoparticles
Nanomedicine 2020cited by 21position: middledoi
E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis.
2020cited by 21position: contributordoi
Diagnostic Accuracy of Interferon Gamma-Induced Protein 10 mRNA Release Assay for Tuberculosis.
2020cited by 11position: contributordoi
Clinical implications of molecular drug resistance testing for &lt;I&gt;Mycobacterium tuberculosis&lt;/I&gt;: a TBNET/RESIST-TB consensus statement
The International Journal of Tuberculosis and Lung Disease 2015cited by 132position: firstdoi
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study
American Journal of Respiratory and Critical Care Medicine 2015cited by 116position: middledoi
Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study
American Journal of Respiratory and Critical Care Medicine 2014cited by 261position: middledoi
False-negative interferon-γ release assay results in active tuberculosis: a TBNET study
European Respiratory Journal 2014cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Cristina Prat · Utrecht University7 papers (2020–2022) · 3 papers (2020–2022) · 3 papers (2020–2022) · 3 papers (2020–2026) · 3 papers (2020–2021) · 3 papers (2020–2021)Bárbara Molina-Moya · Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol3 papers (2015–2021)Luís E. Cuevas · Liverpool School of Tropical Medicine3 papers (2020–2023) · 2 papers (2020–2022)Cristina Prat · Utrecht University2 papers (2020–2020) · 2 papers (2020–2022)Ramón Campos‐Olivas · McGill University2 papers (2020–2021)Irene Latorre · Universitat de Barcelona2 papers (2022–2022)José Luis Izquierdo-García · Universidad Complutense de Madrid2 papers (2020–2021)Esther García-García · Universitat de Barcelona2 papers (2020–2020)Lorenzo Guglielmetti · Ospedale Sacro Cuore Don Calabria2 papers (2020–2021)Christoph Lange · Médecins Sans Frontières2 papers (2015–2021) · 2 papers (2020–2021) · 2 papers (2020–2022)Francis Varaine · National University of Singapore1 papers (2020–2020)